Hubei Goto Biopharm Statistics

Total Valuation

SHE:300966 has a market cap or net worth of CNY 1.97 billion. The enterprise value is 3.12 billion.

Market Cap	1.97B
Enterprise Value	3.12B

Important Dates

The last earnings date was Thursday, April 24, 2025.

Earnings Date	Apr 24, 2025
Ex-Dividend Date	n/a

Share Statistics

SHE:300966 has 115.28 million shares outstanding. The number of shares has decreased by -0.05% in one year.

Current Share Class	115.28M
Shares Outstanding	115.28M
Shares Change (YoY)	-0.05%
Shares Change (QoQ)	+7.82%
Owned by Insiders (%)	44.66%
Owned by Institutions (%)	3.33%
Float	54.20M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.57
PB Ratio	1.95
P/TBV Ratio	2.26
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 65.60, with an EV/FCF ratio of -8.64.

EV / Earnings	-103.72
EV / Sales	5.63
EV / EBITDA	65.60
EV / EBIT	n/a
EV / FCF	-8.64

Financial Position

The company has a current ratio of 1.05, with a Debt / Equity ratio of 1.20.

Current Ratio	1.05
Quick Ratio	0.49
Debt / Equity	1.20
Debt / EBITDA	25.49
Debt / FCF	-3.36
Interest Coverage	0.02

Financial Efficiency

Return on equity (ROE) is -3.46% and return on invested capital (ROIC) is 0.00%.

Return on Equity (ROE)	-3.46%
Return on Assets (ROA)	0.00%
Return on Invested Capital (ROIC)	0.00%
Return on Capital Employed (ROCE)	0.01%
Revenue Per Employee	877,312
Profits Per Employee	-47,633
Employee Count	631
Asset Turnover	0.21
Inventory Turnover	1.10

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -16.89% in the last 52 weeks. The beta is 0.12, so SHE:300966's price volatility has been lower than the market average.

Beta (5Y)	0.12
52-Week Price Change	-16.89%
50-Day Moving Average	16.39
200-Day Moving Average	16.69
Relative Strength Index (RSI)	61.26
Average Volume (20 Days)	2,111,919

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SHE:300966 had revenue of CNY 553.58 million and -30.06 million in losses. Loss per share was -0.27.

Revenue	553.58M
Gross Profit	112.95M
Operating Income	151,819
Pretax Income	-51.85M
Net Income	-30.06M
EBITDA	47.26M
EBIT	151,819
Loss Per Share	-0.27

Full Income Statement

Balance Sheet

The company has 157.14 million in cash and 1.21 billion in debt, giving a net cash position of -1.05 billion or -9.15 per share.

Cash & Cash Equivalents	157.14M
Total Debt	1.21B
Net Cash	-1.05B
Net Cash Per Share	-9.15
Equity (Book Value)	1.01B
Book Value Per Share	8.52
Working Capital	45.10M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -25.14 million and capital expenditures -335.64 million, giving a free cash flow of -360.78 million.

Operating Cash Flow	-25.14M
Capital Expenditures	-335.64M
Free Cash Flow	-360.78M
FCF Per Share	-3.13

Full Cash Flow Statement

Margins

Gross margin is 20.40%, with operating and profit margins of 0.03% and -5.43%.

Gross Margin	20.40%
Operating Margin	0.03%
Pretax Margin	-9.37%
Profit Margin	-5.43%
EBITDA Margin	8.54%
EBIT Margin	0.03%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.02, which amounts to a dividend yield of 0.10%.

Dividend Per Share	0.02
Dividend Yield	0.10%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.05%
Shareholder Yield	0.15%
Earnings Yield	-1.52%
FCF Yield	-18.28%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a